Regis Healthcare Ltd (ASX: REG) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Regis Healthcare Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $536.99 million
P/E Ratio 26.32
Dividend Yield 3.80%
Shares Outstanding 300.83 million
Earnings per share 0.066
Dividend per share 0.07
Year To Date Return -6.68%
Earnings Yield 3.80%
Franking 50%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Regis Healthcare Ltd (ASX: REG)
Latest News

beat the share market
Share Gainers

Why Accent, Mesoblast, Redbubble, & Regis Healthcare shares are charging higher

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positive note. At …

Read more »

Transurban share price ASX shares upgrade to buy asx 200 share price upgrade to buy represented by hand drawing line under the word upgrade
Mergers & Acquisitions

Takeover battle for Regis (ASX:REG) share price triggers sector-wide upgrade

The takeover bid didn’t only send the Regis Healthcare Ltd (ASX: REG) share price soaring. It triggered a re-rating among …

Read more »

Mergers & Acquisitions

Washington H. Soul Pattinson (ASX:SOL) launches Regis Healthcare (ASX:REG) takeover

The Regis Healthcare Ltd (ASX: REG) share price will be on watch on Friday after a late announcement relating to …

Read more »

ASX Small Caps
Share Market News

Broker picks best ASX small cap stocks to buy from the reporting season

Last month’s reporting season turned out to be less frightful than many were expecting. But I think the ASX small …

Read more »

Red arrow downward chart
Share Market News

Regis share price drops on poor FY20 results

The Regis Healthcare Ltd (ASX: REG) share price has dropped 3.7% today following the release of FY20 results. Regis Healthcare …

Read more »

Share Market News

Why Jumbo, Monash IVF, Regis Healthcare, & Ramelius are dropping lower

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to start the month on a high. …

Read more »

shares for retirement
Share Market News

Regis Healthcare shares tumble as profits halve

The Regis Healthcare Ltd (ASX: REG) share price is falling sharply today following a negative market reaction to the release …

Read more »

Make a comeback
Healthcare Shares

Can these 2 ASX healthcare shares recover in 2020?

The Aussie sharemarket enjoyed a year of healthy returns in 2019. The S&P/ASX 200 (INDEXASX: XJO) was up 18% over …

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
15 Sep 2021 $0.0464 50.00% Final 30 Sep 2021
10 Mar 2021 $0.0200 50.00% Interim 08 Apr 2021
11 Mar 2020 $0.0402 50.00% Interim 30 Sep 2020
11 Sep 2019 $0.0711 100.00% Final 26 Sep 2019
13 Mar 2019 $0.0812 100.00% Interim 11 Apr 2019
11 Sep 2018 $0.0865 100.00% Final 26 Sep 2018
13 Mar 2018 $0.0928 100.00% Interim 11 Apr 2018
01 Sep 2017 $0.1004 100.00% Final 18 Sep 2017
03 Mar 2017 $0.1030 100.00% Interim 20 Mar 2017
02 Sep 2016 $0.0594 100.00% Final 19 Sep 2016
03 Mar 2016 $0.0940 100.00% Interim 21 Mar 2016
03 Sep 2015 $0.1760 64.20% 21 Sep 2015

REG ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Regis Healthcare Ltd

Regis Healthcare Ltd provides residential care for the elderly in Australia, including respite, dementia-specific, and palliative care. The firm's facilities are primarily located in metropolitan areas and a majority of its rooms offered are single bedrooms. The majority of Regis' revenue comes from government funding due to the highly regulated environment for aged care facilities in Australia, though the firm also receives resident fees.

REG Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
27 Jan 2022 $1.75 $0.00 0.00% 340,086 $1.75 $1.80 $1.73
25 Jan 2022 $1.75 $-0.04 -2.23% 602,771 $1.78 $1.78 $1.71
24 Jan 2022 $1.79 $-0.03 -1.65% 284,788 $1.82 $1.82 $1.76
21 Jan 2022 $1.82 $0.00 0.00% 192,118 $1.82 $1.85 $1.81
20 Jan 2022 $1.82 $-0.02 -1.09% 223,887 $1.83 $1.83 $1.81
19 Jan 2022 $1.84 $0.02 1.10% 124,203 $1.82 $1.86 $1.82
18 Jan 2022 $1.82 $-0.01 -0.54% 93,633 $1.84 $1.86 $1.82
17 Jan 2022 $1.84 $0.01 0.55% 671,562 $1.84 $1.85 $1.82
14 Jan 2022 $1.82 $0.00 0.00% 172,327 $1.82 $1.83 $1.80
13 Jan 2022 $1.83 $-0.02 -1.08% 217,915 $1.84 $1.84 $1.80
12 Jan 2022 $1.85 $0.01 0.55% 65,645 $1.83 $1.85 $1.83
11 Jan 2022 $1.83 $-0.01 -0.54% 75,227 $1.81 $1.84 $1.81
10 Jan 2022 $1.84 $0.03 1.65% 158,795 $1.85 $1.85 $1.78
07 Jan 2022 $1.82 $-0.04 -2.16% 71,175 $1.85 $1.88 $1.82
06 Jan 2022 $1.86 $-0.04 -2.11% 1,128,219 $1.85 $1.88 $1.82
05 Jan 2022 $1.90 $0.01 0.53% 366,337 $1.90 $1.90 $1.86
04 Jan 2022 $1.89 $0.01 0.53% 115,179 $1.85 $1.89 $1.84
31 Dec 2021 $1.87 $0.01 0.54% 72,049 $1.87 $1.87 $1.84
30 Dec 2021 $1.86 $0.01 0.54% 112,940 $1.85 $1.87 $1.83

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
17 Nov 2021 Linda Mellors Issued 76 $158,400
Issue of securities. 76,893 - Rights
VWAP

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Graham Hodges Non-Executive DirectorNon-Executive Chairman Aug 2017
Mr Hodges has international experience in the financial services industry with a career spanning more than 40 years. He commenced his career in Commonwealth Treasury, Canberra, where he worked for approximately 10 years before being seconded to the International Monetary Fund in Washington for several years. For 28 years, Graham built an executive career at the Australian and New Zealand Banking Group Limited and was formerly the Deputy Chief Executive Officer, ANZ Banking Group Ltd. Graham is currently a Director of AmBank Holdings Berhad (stepping down on 2 September 2021) and Assemble Communities Pty Ltd, and was previously Chairman of ANZ SAM Board (Special Assets Management), Esanda, ANZ Wealth, and a member of the Australian Government's Aged Care Financing Authority. He is a member fo the People and Risk Compliance committee.
Professor Christine Constance Bennett Non-Executive Director Mar 2018
Prof Bennett has over 30 years of health industry experience in clinical care and governance, strategic planning, executive management, teaching and research. She is Deputy Vice Chancellor Enterprise & Partnerships and Head of the School of Medicine, Sydney, at The University of Notre Dame Australia. Christine is also Convenor of the Champions of Change Coalition Health Group and joined the Telstra Health Board in July 2020. Previously, Christine was a Group Executive and Chief Medical Officer at both MBF Limited and Bupa Australia, a Partner in the KPMG Health and Life Sciences Practice, CEO of Westmead Hospital, Chair of the Sydney Children's Hospitals Network and Non-Executive Director of Digital Health CRC Limited. From 2008 to 2010, Christine was Chair of the National Health and Hospitals Reform Commission to provide advice on a long-term plan for the future of the Australian health and aged care system. Prof Bennett is chair of the Chairman of the Clinical Governance and Care Committee.
Mr Bryan Dorman Non-Executive Director May 2007
Mr Dorman has experience working in enterprises across a broad range of industry sectors, including residential aged care, manufacturing, property development, asset investment and business services. Bryan was a Partner in Melbourne accounting firm Rees Partners from 1977 until 2000 and is a qualified accountant. Bryan is a founding Director and shareholder of Regis. From its commencement in the early 1990s until 2014, Bryan was Chairman (and Executive Chairman until 2008), during which time he oversaw the management and growth of the Group. Bryan was also the National President of the former aged care industry body, The Aged Care Association of Australia, from 2004 to 2012, and was actively involved in the development of the industry and shaping its future. He is a member of the Risk, Compliance, Clinical Governance and Care Committee.
Mr Ian Gregory Roberts Non-Executive Director May 2007
Mr Roberts has over 30 years of experience in the real estate sector including 20 years in residential aged care. Prior to co-leading the Regis journey, Ian was involved in property development (sub-divisional and commercial) in South East Queensland. Ian is currently a Non-Executive Director of several property and property services enterprises. He is a member of the People committee.
Dr Linda Jane Mellors Chief Executive OfficerManaging Director Aug 2019
Mr Mellors has nearly 20 years of executive experience in health and aged care. Prior to joining Regis, Linda held a range of roles in hospital and health systems in Victoria, as well as a national aged care service. Linda is currently a Board Director of Mackillop Family Services and inaugural Chair of the Aged Care Reform Network. Linda was formerly the Chair of the Aged Care Guild, Co-Chair of the Victorian Metropolitan Hospital Chief Executive group, Chair of the North Eastern Metropolitan Integrated Cancer Service, Board Member of the Parent Infant Research Institute and Board Director of the South West Melbourne Medicare Local.
Ms Sally Margaret Freeman Non-Executive Director Jan 2022
Ms Freeman has career spans over 25 years, having worked as a Partner at KPMG and Ernst & Young, with a focus on audit and risk management. She has consulted across many levels of both the public and private sectors and worked in London, Singapore, Perth and Melbourne. Sally is currently a non-executive Director of ASX-listed Netwealth Group Limited (including Chair of the Audit Committee) and Netwealth Superannuation Services. Sally is also a non-executive Director of Eastern Health, the Regional Investment Corporation, and the Melbourne Football Club and is an independent member of the audit committees at Healthshare Victoria, Caulfield Grammar School and Commonwealth Games Australia. Sally will also chair the Risk and Compliance Committee of REG.
Ms Rebecca Dean Company Secretary Jul 2020
-
Mr Malcolm Peter Ross Company SecretaryGeneral Counsel Nov 2021
-
Imtiaz Bhayat Chief Information Officer
-
Gregg Funston Executive General Manager Support Services
-
Rick Rostolis Chief Financial Officer
-
Rebecca Dean Company Secretary
-
Malcolm Peter Ross Company SecretaryGeneral Counsel
-
Melissa McDonald Executive General Manager Clinical and Care Practice
-
Gaylene Coulton Executive General Manager Operations - QLD/NSW/NT/Retirement Living
-
Catherine Buttigieg Executive General Manager People and Culture
-
Filomena Ciavarella Executive General Manager Strategy Quality and Improvement
-
Paul Cohen Executive General Manager Operations - VIC/SA/WA/TAS/Home Care
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Ashburn Pty Ltd Acn 005 883 438 81,910,479 27.23%
Galabay Pty Ltd Acn 010 849 153 81,910,479 27.23%
Citicorp Nominees Pty Limited 26,330,445 8.75%
HSBC Custody Nominees (Australia) Limited 22,550,947 7.50%
Buttonwood Nominees Pty Ltd 13,768,346 4.58%
J P Morgan Nominees Australia Pty Limited 8,717,028 2.90%
Mr David Qian Lee 5,303,888 1.76%
BNP Paribas Noms Pty Ltd 3,501,408 1.16%
Mr Ross James Johnston 2,245,000 0.75%
Mr Vincent Michael O'Sullivan 2,192,000 0.73%
Bki Investment Company Limited 1,807,428 0.60%
BNP Paribas Nominees Pty Ltd 1,763,889 0.59%
Cs Fourth Nominees Pty Limited 1,447,626 0.48%
National Nominees Limited 1,298,033 0.43%
Australian Executor Trustees Limited 1,246,449 0.41%
UBS Nominees Pty Ltd 1,165,082 0.39%
Bundarra Trading Company Pty Ltd 852,671 0.28%
HSBC Custody Nominees (Australia) Limited (i) 850,000 0.28%
Ballian Investments Pty Ltd 787,934 0.26%
Canto Holdings Pty Ltd 785,548 0.26%
Netwealth Investments Limited 783,742 0.26%

Profile

since

Note